Got nothing to do with MSB. It's just usual business behaviour for any company and they simply have reaffirmed their commitment to the CNS area anyways which our heart trial falls into.
http://www.marketwatch.com/story/te...f-core-specialty-therapeutic-areas-2014-10-06
MSB 0_o, page-37
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.3¢ |
Change
-0.013(1.30%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $1.176M | 1.230M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 188424 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 73263 | 40 |
View Market Depth
| Last trade - 13.03pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |